Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #251 to #500.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Hounsfield unit‏‎ (2 revisions)
  2. Authorized limit‏‎ (2 revisions)
  3. Specific effective energy‏‎ (2 revisions)
  4. Cardiac arrhythmias‏‎ (2 revisions)
  5. Lineal energy‏‎ (2 revisions)
  6. Thyroid blocking‏‎ (2 revisions)
  7. Transparency‏‎ (2 revisions)
  8. Waste disposal‏‎ (2 revisions)
  9. Non-targeted effects‏‎ (2 revisions)
  10. Disposal‏‎ (2 revisions)
  11. Dose criteria‏‎ (2 revisions)
  12. Procedural values‏‎ (2 revisions)
  13. Environmental exposure‏‎ (2 revisions)
  14. Exempt waste‏‎ (2 revisions)
  15. Adaptive response‏‎ (2 revisions)
  16. Reproductive integrity‏‎ (2 revisions)
  17. Alveolar-interstitial region‏‎ (2 revisions)
  18. Safety case‏‎ (2 revisions)
  19. Autoimmune disease‏‎ (2 revisions)
  20. Slow repair‏‎ (2 revisions)
  21. Isotropic geometry‏‎ (2 revisions)
  22. ICRP Publication 118‏‎ (2 revisions)
  23. Cardiac valve diseases‏‎ (2 revisions)
  24. Linear-non-threshold model‏‎ (2 revisions)
  25. Co-expertise‏‎ (2 revisions)
  26. Connective tissue‏‎ (2 revisions)
  27. Trapped particles‏‎ (2 revisions)
  28. DRL process‏‎ (2 revisions)
  29. Orphan source‏‎ (2 revisions)
  30. Planned exposure situation‏‎ (2 revisions)
  31. Progenitor cell‏‎ (2 revisions)
  32. Radiation belt‏‎ (2 revisions - redirect page)
  33. Environmental radiation protection‏‎ (2 revisions)
  34. Exemption level‏‎ (2 revisions)
  35. Reasonableness‏‎ (2 revisions)
  36. Residual dose‏‎ (2 revisions)
  37. Safety culture‏‎ (2 revisions)
  38. Solar cosmic radiation‏‎ (2 revisions)
  39. Inhalability‏‎ (2 revisions)
  40. Spontaneous fission‏‎ (2 revisions)
  41. Itinerant (radiation) worker‏‎ (2 revisions)
  42. Systemic model‏‎ (2 revisions)
  43. Linear-quadratic dose response model‏‎ (2 revisions)
  44. Time factor‏‎ (2 revisions)
  45. Consequential late effects‏‎ (2 revisions)
  46. Myocardial perfusion‏‎ (2 revisions)
  47. What is Radon?‏‎ (2 revisions)
  48. Platelet-derived growth factor‏‎ (2 revisions)
  49. Effective dose equivalent‏‎ (2 revisions)
  50. Radiation modifier‏‎ (2 revisions)
  51. Radiological protection principles‏‎ (2 revisions)
  52. Existing exposure situation‏‎ (2 revisions)
  53. Gastroschisis‏‎ (2 revisions)
  54. Respiratory protection‏‎ (2 revisions)
  55. Angiogenesis‏‎ (2 revisions)
  56. Scintigraphy‏‎ (2 revisions)
  57. Hyperbaric oxygen‏‎ (2 revisions)
  58. Solar cycle‏‎ (2 revisions)
  59. Inner bremsstrahlung‏‎ (2 revisions)
  60. Bioturbation‏‎ (2 revisions)
  61. Cardioverter-defibrillator‏‎ (2 revisions)
  62. Tachycardia‏‎ (2 revisions)
  63. Cohort study‏‎ (2 revisions)
  64. Tissue equivalent material‏‎ (2 revisions)
  65. Myocardial stress test‏‎ (2 revisions)
  66. DRL value‏‎ (2 revisions)
  67. Oversight‏‎ (2 revisions)
  68. Projected dose‏‎ (2 revisions)
  69. Epithelium‏‎ (2 revisions)
  70. Radionuclides of natural origin‏‎ (2 revisions)
  71. Recovery (cellular or tissue)‏‎ (2 revisions)
  72. Acceptance test‏‎ (2 revisions)
  73. Gastrulation‏‎ (2 revisions)
  74. Retrievability‏‎ (2 revisions)
  75. Habitual mouth breather‏‎ (2 revisions)
  76. Annihilation photons‏‎ (2 revisions)
  77. Immune system‏‎ (2 revisions)
  78. Hyperfractionation‏‎ (2 revisions)
  79. Institutional control‏‎ (2 revisions)
  80. Bone marrow‏‎ (2 revisions)
  81. Stakeholder‏‎ (2 revisions)
  82. Containment‏‎ (2 revisions)
  83. Worker‏‎ (2 revisions)
  84. Nuclear track detectors‏‎ (2 revisions)
  85. Dose-length product‏‎ (2 revisions)
  86. Radiation safety officer‏‎ (2 revisions)
  87. Equieffective dose‏‎ (2 revisions)
  88. Radioresponsiveness‏‎ (2 revisions)
  89. Expanded and aligned radiation field‏‎ (2 revisions)
  90. Recovery responder‏‎ (2 revisions)
  91. Adventitious‏‎ (2 revisions)
  92. Reversibility‏‎ (2 revisions)
  93. Habitual nose breather‏‎ (2 revisions)
  94. In vivo radiobioassay‏‎ (2 revisions)
  95. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  96. Background dose (rate)‏‎ (2 revisions)
  97. Solar particle event‏‎ (2 revisions)
  98. Target tissue‏‎ (2 revisions)
  99. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  100. Working level‏‎ (2 revisions)
  101. OLINDA/EXM‏‎ (2 revisions)
  102. Detriment‏‎ (2 revisions)
  103. Particle radiance‏‎ (2 revisions)
  104. Dose-rate effect‏‎ (2 revisions)
  105. Protection strategy‏‎ (2 revisions)
  106. Electron-capture decay‏‎ (2 revisions)
  107. Radiation source‏‎ (2 revisions)
  108. Radiosensitiser‏‎ (2 revisions)
  109. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  110. Rehabilitation of living conditions‏‎ (2 revisions)
  111. Right to know‏‎ (2 revisions)
  112. Incidence‏‎ (2 revisions)
  113. Hypoplasia‏‎ (2 revisions)
  114. Backscatter detection system‏‎ (2 revisions)
  115. Solar wind‏‎ (2 revisions)
  116. Bradycardia‏‎ (2 revisions)
  117. Local DRL‏‎ (2 revisions)
  118. Tolerability‏‎ (2 revisions)
  119. Medical exposure‏‎ (2 revisions)
  120. Coronary heart disease‏‎ (2 revisions)
  121. Naturally occurring radioactive material‏‎ (2 revisions)
  122. Decay constant‏‎ (2 revisions)
  123. Working level month‏‎ (2 revisions)
  124. Dose of record Hp (10)‏‎ (2 revisions)
  125. Electrophysiology‏‎ (2 revisions)
  126. Radiosensitivity, cellular‏‎ (2 revisions)
  127. Accreditation‏‎ (2 revisions)
  128. Genomic integrity‏‎ (2 revisions)
  129. Rigidity‏‎ (2 revisions)
  130. Hazard‏‎ (2 revisions)
  131. Security‏‎ (2 revisions)
  132. Incident‏‎ (2 revisions)
  133. Intermediate level waste‏‎ (2 revisions)
  134. Bragg peak‏‎ (2 revisions)
  135. Stenosis‏‎ (2 revisions)
  136. Chronic exposure‏‎ (2 revisions)
  137. Telangiectasia‏‎ (2 revisions)
  138. Colony‏‎ (2 revisions)
  139. Member of the public‏‎ (2 revisions)
  140. Cosmic Radiation in Aviation‏‎ (2 revisions)
  141. Unattached fraction‏‎ (2 revisions)
  142. Necrosis‏‎ (2 revisions)
  143. Decommissioning‏‎ (2 revisions)
  144. Patient entrance reference point‏‎ (2 revisions)
  145. Dose-threshold‏‎ (2 revisions)
  146. Potential recoverability correction factor‏‎ (2 revisions)
  147. Protective action guide‏‎ (2 revisions)
  148. Radiation worker‏‎ (2 revisions)
  149. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  150. Action Level‏‎ (2 revisions)
  151. Health Surveillance‏‎ (2 revisions)
  152. Inclusiveness‏‎ (2 revisions)
  153. Basal cell‏‎ (2 revisions)
  154. Source-related‏‎ (2 revisions)
  155. Internal conversion electron‏‎ (2 revisions)
  156. Branching fraction‏‎ (2 revisions)
  157. LD 50/30‏‎ (2 revisions)
  158. Class SR-0 gases‏‎ (2 revisions)
  159. Track structure‏‎ (2 revisions)
  160. Mendelian diseases‏‎ (2 revisions)
  161. Neurological syndrome‏‎ (2 revisions)
  162. Decontamination‏‎ (2 revisions)
  163. Occupational exposure‏‎ (2 revisions)
  164. Diastasis‏‎ (2 revisions)
  165. Peak skin dose‏‎ (2 revisions)
  166. Dose per unit intake coefficient‏‎ (2 revisions)
  167. Emergency‏‎ (2 revisions)
  168. Radioactive dispersion device‏‎ (2 revisions)
  169. Radon: Units of Measure‏‎ (2 revisions)
  170. Exposure, external or internal‏‎ (2 revisions)
  171. Reference air kerma‏‎ (2 revisions)
  172. Graft vs host disease‏‎ (2 revisions)
  173. Air-kerma, incident‏‎ (2 revisions)
  174. Heliosphere‏‎ (2 revisions)
  175. Self-help protection‏‎ (2 revisions)
  176. Individual-related‏‎ (2 revisions)
  177. Storage‏‎ (2 revisions)
  178. Class SR-1 gases‏‎ (2 revisions)
  179. Low dose rate‏‎ (2 revisions)
  180. Committed effective dose‏‎ (2 revisions)
  181. Transfer compartment‏‎ (2 revisions)
  182. Mitigation‏‎ (2 revisions)
  183. Cost-benefit analysis‏‎ (2 revisions)
  184. Upper reference levels‏‎ (2 revisions)
  185. Neurovascular syndrome‏‎ (2 revisions)
  186. Decontamination factor‏‎ (2 revisions)
  187. Pelagic‏‎ (2 revisions)
  188. Practical radiological protection culture‏‎ (2 revisions)
  189. Dose rate‏‎ (2 revisions)
  190. Emergency exposure situation‏‎ (2 revisions)
  191. Radioactive source‏‎ (2 revisions)
  192. Erythropoietin‏‎ (2 revisions)
  193. Exposure (in the context of inhalation)‏‎ (2 revisions)
  194. Fractionation and dose delivery patterns‏‎ (2 revisions)
  195. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  196. Individual decontamination‏‎ (2 revisions)
  197. Broad beam therapy irradiation technique‏‎ (2 revisions)
  198. Subcutaneous tissue‏‎ (2 revisions)
  199. Sublethal damage repair‏‎ (1 revision)
  200. ICRP Publication 127‏‎ (1 revision)
  201. ICRP Publication 141‏‎ (1 revision)
  202. Transfer of risk‏‎ (1 revision)
  203. Molecular imaging‏‎ (1 revision)
  204. ICRP Publication 16‏‎ (1 revision)
  205. Noise‏‎ (1 revision)
  206. ICRP Publication 30‏‎ (1 revision)
  207. Dental and maxillofacial imaging‏‎ (1 revision)
  208. ΓH2AX foci‏‎ (1 revision)
  209. Operating management‏‎ (1 revision)
  210. ICRP Publication 37‏‎ (1 revision)
  211. Pencil beam‏‎ (1 revision)
  212. ICRP Publication 51‏‎ (1 revision)
  213. Practice‏‎ (1 revision)
  214. ICRP Publication 66‏‎ (1 revision)
  215. ICRP Publication 80‏‎ (1 revision)
  216. Active detection system‏‎ (1 revision)
  217. Severe deterministic injury‏‎ (1 revision)
  218. ICRP Publication 100‏‎ (1 revision)
  219. Intervention‏‎ (1 revision)
  220. ICRP Publication 112‏‎ (1 revision)
  221. Licensee‏‎ (1 revision)
  222. ICRP Publication 128‏‎ (1 revision)
  223. Thermodynamic diameter‏‎ (1 revision)
  224. Low linear energy transfer radiation‏‎ (1 revision)
  225. ICRP Publication 142‏‎ (1 revision)
  226. Compartment‏‎ (1 revision)
  227. ICRP Publication 17‏‎ (1 revision)
  228. Count median diameter‏‎ (1 revision)
  229. Nominal risk coefficient‏‎ (1 revision)
  230. ICRP Publication 30 (Index)‏‎ (1 revision)
  231. ICRP Publication 38‏‎ (1 revision)
  232. ICRP Publication 52‏‎ (1 revision)
  233. Dose commitment‏‎ (1 revision)
  234. ICRP Publication 67‏‎ (1 revision)
  235. Doubling dose‏‎ (1 revision)
  236. Quality control testing‏‎ (1 revision)
  237. ICRP Publication 81‏‎ (1 revision)
  238. Radioactive waste‏‎ (1 revision)
  239. Evacuation‏‎ (1 revision)
  240. Exposure index‏‎ (1 revision)
  241. AML/eto‏‎ (1 revision)
  242. Frequent flyer‏‎ (1 revision)
  243. Risk model‏‎ (1 revision)
  244. Attributable risk‏‎ (1 revision)
  245. Sheltering‏‎ (1 revision)
  246. Induced genomic instability‏‎ (1 revision)
  247. ICRP Publication 101‏‎ (1 revision)
  248. Best available techniques‏‎ (1 revision)
  249. ICRP Publication 113‏‎ (1 revision)
  250. Bronchiolar region‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)